Clinical Trial Update: Usefulness of Corifollitropin α as Alternative to Conventional Daily rFSH Protocols in Oocyte Donors Undergoing Pituitary Suppression With Medroxiprogesterona Acetate (MPA) [NA]

View source ↗

Summary

A clinical trial evaluating corifollitropin alfa as an alternative to conventional daily rFSH protocols for oocyte donors undergoing pituitary suppression with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility
• Sterility

Drugs mentioned

• Corifollitropin alfa (Corifollitropin alfa)

Snippet

Sponsor: Instituto Valenciano de Infertilidad, IVI VALENCIA | Conditions: Infertility, Female, Reproductive Sterility | NA | Status: RECRUITING